Caution urged for off-label glucose-lowering drugs in type 1 diabetes
Off-label SGLT2 inhibitors increase the risk of euglycemic diabetic ketoacidosis. GLP-1RAs may lead to rapid weight loss in type 1 diabetes, …
Off-label SGLT2 inhibitors increase the risk of euglycemic diabetic ketoacidosis. GLP-1RAs may lead to rapid weight loss in type 1 diabetes, …